2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC2581 | |||||||||||||||||||||||
Submitter : | Ms. Denise Mears | Date & Time: | 02/16/2006 11:02:35 | |||||||||||||||||||||
Organization : | Ms. Denise Mears | |||||||||||||||||||||||
Category : | Health Professional | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
As a prescriber of bio-identical hormones, I believe it is important for these hormones to be available from compounding pharmacists who can individulalize the dose and delvery forms. Taking away this option could be harmful to a patients health due to inadequate/excessive dosing that would result with use of a standardized form. | ||||||||||||||||||||||||